Foresight President weighs in on the possibility of gene patenting via VentureBeat.
Should human genes be patented? The Supreme Court is weighing in today in a landmark case, Association for Molecular Pathology v. Myriad Genetics, Inc., 12-398., that will have an enormous impact on the future of science, technology, and medicine.
Read more at VentureBeat.
Spring is here! Join us in celebrating World Intellectual Property Day on April 26th and the role of IP in encouraging innovation and creativity.
In this newsletter:
- World IP Day Celebrations
- Foresight Presents at Product Management Event 2013, San Francisco, CA
- LES Silicon Valley and Foresight Panel Discussion at Carr & Ferrell, Menlo Park, CA
- American Invents Act (AIA) Changes
- Upcoming Events Sponsored by Foresight or featuring Foresight Speakers
We thank you for attending our LES co-sponsored event at Carr&Ferrell and hope you found it to be informative and thought provoking. The turn out was great and we received amazing feedback on the quality of the speakers and relevant content. We look forward to seeing you at the next LES event!
A special thank you John Ferrell and Jill Fishbein of IP law firm Carr&Ferrell for co-hosting the panel discussion and providing us with a wonderful venue and lunch.
Understanding the Value of Your Patent Portfolio: A Practical Guide for Business Executives.
The value of patent portfolios is often shrouded in mystery, due to the lack of transparency associated with IP transactions. The media coverage of some of the recent multi-billion dollar patent deals has allowed a rare glimpse into the financial value of these assets.The multidisciplinary panel will provided a practical guide to understanding the value of a company’s patent portfolio from the viewpoint of a variety of stakeholders. The panel presented a rounded view of the methods applied and factors considered in the valuation and assessment of patents as they relate to the corporate IP holder.
DESCRIPTION The value of patent portfolios is often shrouded in mystery, due to the lack of transparency associated with IP transactions. The media coverage of some of the recent multi-billion dollar patent deals has allowed a rare glimpse into the financial value of these assets.
This multidisciplinary panel will provide a practical guide to understanding the value of a company’s patent portfolio from the viewpoint of a variety of stakeholders. The panel will present a rounded view of the methods applied and factors considered in the valuation and assessment of patents as they relate to the corporate IP holder.
The discussion will focus on the types of transactions/ circumstances when IP valuation is required, and will present the different views on valuing patents:
- The transactional view
- The accounting /tax planning view
- The litigation view
- The startup view
Jill Fishbein, Partner, Carr & Ferrell LLP
John Ferrell, Co-Founder, Chair, Carr & Ferrell LLP
Efrat Kasznik, President, Foresight Valuation Group
Mark Kroot, Managing Director, Alto Cumulus IP
Brian Way, Director of IP, Altera
The full presentation slides from each speaker are viewable via LES Silicon Valley here.
is a full-service law firm uniquely positioned to provide strategic patent and intellectual property, corporate, financing and litigation services. Located in the heart of Silicon Valley’s technology and venture capital community, our attorneys leverage their technical, business and legal expertise to help emerging companies and investors transform business concepts into industry leading enterprises. A strong and focused firm, we have made senior level attention a hallmark of our clients’ experience.
is a Silicon Valley based Intellectual Property consulting firm, specializing in IP valuation, strategy and litigation support services. If you’re interested in exploring ways in which we can bring value to your clients, please contact us at firstname.lastname@example.org.